http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002512262-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
filingDate | 1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002512262-A |
titleOfInvention | R-Rave prazole compositions and methods |
abstract | PROBLEM TO BE SOLVED: To provide a method for treating and preventing ulcer, a method for treating other conditions related to gastric hypersecretion, and a method for treating psoriasis. A method and composition utilizing optically pure (+) rabeprazole to treat human ulcers while simultaneously producing the deleterious effects associated with the racemic mixture of raiveprazole. Methods and compositions are provided that substantially reduce This optically pure (+) isomer is also useful for treating gastroesophageal reflux. (+) Reibprazole is an inhibitor of H + release and is therefore useful in treating other conditions associated with gastric hypersecretion, such as Zollinger-Ellison syndrome. |
priorityDate | 1998-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.